New CAR-T therapy battle: Two-Pronged attack vs. transplant bridge for tough leukemia
NCT ID NCT06343090
Summary
This study is comparing two advanced cell therapy approaches for patients with B-cell acute lymphoblastic leukemia that has returned or not responded to previous treatments. One approach uses two different CAR-T cell infusions in sequence, while the other uses one CAR-T cell infusion followed by a stem cell transplant. The trial aims to see which approach helps patients live longer without their cancer returning.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing GoBroad Hospital
RECRUITINGBeijing, Beijing Municipality, 102206, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.